Amundi
IMVT icon

Amundi’s Immunovant IMVT Stock Holding History

Amundi’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.66M Sell
66,848
-556
-0.8% -$14.4K ﹤0.01% 1149
2025
Q4 		$1.71M Buy
+67,404
New +$1.5M ﹤0.01% 1190
2025
Q2 		– Sell
-2,593
Closed -$40.9K – 1909
2025
Q1 		$40.9K Hold
2,593
– – ﹤0.01% 1828
2024
Q4 		$61.3K Hold
2,593
– – ﹤0.01% 1833
2024
Q3 		$76.8K Sell
2,593
-621
-19% -$18.3K ﹤0.01% 1802
2024
Q2 		$84.2K Hold
3,214
– – ﹤0.01% 1726
2024
Q1 		$91K Hold
3,214
– – ﹤0.01% 1779
2023
Q4 		$141K Sell
3,214
-402
-11% -$14.8K ﹤0.01% 1711
2023
Q3 		$135K Hold
3,616
– – ﹤0.01% 1697
2023
Q2 		$67.8K Hold
3,616
– – ﹤0.01% 1854
2023
Q1 		$51.9K Hold
3,616
– – ﹤0.01% 1880
2022
Q4 		$63.8K Buy
+3,616
New +$45.5K ﹤0.01% 1667

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return